These results indicate that hsa_circ_0001846 can promote the progression of PC through miR-204-3p/KRAS pathway, suggesting that hsa_circ_0001846 may be a potential biomarker for clinical diagnosis and treatment of PC. The gene discussed is KRAS; the disease is pachyonychia congenita.